Michael Grundman
5Patents
4h-index
14Co-inventors
46Inventor score
Filing activity: Jul 27, 2007 → Jul 2, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8613920B2 | Treatment of amyloidogenic diseases | Chemistry; Metallurgy | 40 | Active |
| US8784810B2 | Treatment of amyloidogenic diseases | Chemistry; Metallurgy | 16 | Active |
| US9644025B2 | Immunotherapy regimes dependent on ApoE status | Chemistry; Metallurgy | 10 | Active |
| US10513555B2 | Antibody formulations and methods | Chemistry; Metallurgy | 5 | Active |
| US9272030B2 | Use of tau to monitor immunotherapy | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.